http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022079506-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7de02e4b28736bfb52de8bb358be203e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-20044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V2201-03
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-0025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-398
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V40-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V40-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-398
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
filingDate 2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_610a03c245016dbc003a75e912458627
publicationDate 2022-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022079506-A1
titleOfInvention Systems and method for detecting cognitive impairment
abstract Systems, methods, and computer readable media for determining cognitive impairment (CI) in patients are provided herein. Various regional structural-functional parameters of the retina can serve as biomarkers for the detection of CI. The method can include forming a database including a quantification of retinal structure and retinal function of a plurality of eyes associated with a plurality of patients, providing a baseline cognitive impairment (CI) reference. The method can include determining a measure of functionality of neurons in the retina based on an electroretinogram (ERG) of a patient. The method can include determining a structural measure of the first retina based on a generalized dimension spectrum and singularity spectrum of the skeletonized retinal image, and a lacunarity parameter of the skeletonized retinal image. The method can include determining a level of cognitive impairment based on the structural and functional measures.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116328213-A
priorityDate 2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425965108

Total number of triples: 30.